Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xiulong Traditional Chinese Medicine Factory (later restructured as Shanghai Xiulong Traditional Chinese Medicine Co., Ltd.) was a Chinese pharmaceutical company specializing in traditional Chinese medicine (TCM). Established in 1989, the company manufactured various TCM formulations, including granules, syrups, tablets, and suppositories, at its facility in the Kangqiao Industrial Zone in Pudong, Shanghai. Its product portfolio featured Jixuegan tablets (Centella asiatica tablets) for wound healing, Niuganning granules for urinary tract infections, and Qingchang suppositories for ulcerative colitis. In 2005, the company was restructured and integrated into Shanghai Yigongyuan Pharmaceutical Co., Ltd. (now Shanghai Shyndec Pharmaceutical Marketing Co., Ltd.), a subsidiary of the publicly traded Shanghai Shyndec Pharmaceutical Co., Ltd. (国药现代). The company has since been deregistered.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Xiulong Traditional Chinese Medicine Factory.